19 development-"https:"-"https:"-"https:"-"CentraleSupélec" Postgraduate positions at University of Oxford
Sort by
Refine Your Search
-
The Medical Sciences Division is seeking to appoint to the post of Researcher Development and Training Manager. This senior post has wide-ranging responsibility for the University of Oxford Medical
-
funded by the University and by NaturalMotion Ltd. NaturalMotion Ltd develops computational methods for animating movement, as used in Hollywood films and computer games. The founder, Torsten Reil, is an
-
and the Thatcher Development Programme at Somerville College. The late Lady Thatcher studied Chemistry at Somerville College Oxford from 1943 to 1946 and received bursary and scholarship support from
-
are commencing an MSc Economics for Development or MPhil Economics, or a master’s course in the fields of global, social, environmental or political studies. The Oxford-Catharine French Graduate Scholarship
-
Sustainable Development's agenda of interdisciplinary research on sustainable development and India. The Centre's core research areas are: sustainable cities, climate change and clean energy, healthcare
-
was established in Japan in 1987 with the aim of contributing to the development of society through the promotion of ethics-related academic research, and educational and socio-cultural activities. The scholarships
-
) was an Oxford biochemist who purified penicillin and developed cephalosporin antibiotics. Abraham set up a trust with the royalties he received to support research in the medical, biological and chemical sciences
-
This Research Assistant position supports a UKRI-funded research programme developing anatomy-driven artificial intelligence methods for cognitive and translational neuroscience. The role focuses
-
at four areas: 1) Academic merit and potential 2) Leadership experience and capacity development 3) Alignment with AfOx values and themes 4) Commitment to Africa's development. To be considered
-
recognises his pivotal role in work that led, among others, to the development of CAMPATH monoclonal antibodies, which are now used for the treatment of certain leukaemias and for multiple sclerosis